English | Español

Regulatory
+ Regulatory
Patient Daily | Apr 24, 2026

Steve Forbes on 340B program: Hospitals use it ‘to divert taxpayer-subsidized benefits for patients to unrelated interests’
+ Pharmaceuticals
Patient Daily | Apr 23, 2026

AAFA announces new resources for nasal polyps on Global CRSwNP Awareness Day
+ Pharmaceuticals
Patient Daily | Apr 23, 2026

Experts discuss advancements in diabetes management on Denatured podcast
+ Pharmaceuticals
Patient Daily | Apr 23, 2026

BioSpace report finds persistent gender and racial pay gaps in life sciences industry
Patient Daily | Apr 23, 2026

Health policy advocate raises concerns about 340B program's impact on patients
Patient Daily | Apr 23, 2026

Taxpayers Protection Alliance director says 340B program raises costs for patients and taxpayers
+ Pharmaceuticals
Patient Daily | Apr 23, 2026

Ohio State celebrates organ transplants through Buckeyes for Life program
+ Pharmaceuticals
Patient Daily | Apr 23, 2026

Johnson & Johnson announces $24.1 billion in sales and targets $100 billion revenue in 2026

Trending
+ Regulatory
M. Y. Bailey | Aug 7, 2026

PhRMA's Zirkelbach: 340B program has changed dramatically with 'little transparency into how patients benefit'
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
Patient Daily reports | Aug 10, 2026

SoCal Breathe Free warns persistent sinus symptoms may signal chronic inflammation
+ Pharmaceuticals
Patient Daily | Aug 7, 2026

Researchers develop computer model linking brain chemistry to neural activity patterns